Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

Sangamo Therapeutics Inc., a genomic medicine company, has entered into a license agreement with Eli Lilly and Company.

Veranova has appointed Dr. Scott Zugel as Global Vice President of Analytical Research Development Operations.

George Clinical, a clinical research organization operating worldwide, has rebranded to become Emerald Clinical Trials.

The investment will focus on enhancing infrastructure and technology across all logistics touchpoints, creating resilient, ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Aldeyra received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the resubmission of the NDA ...

Tjoapack has launched its Customer Collaboration Dashboard, a digital platform designed to streamline collaboration between ...

EMAS Pharma has rebranded as Evestia Clinical as it sets its sights on rapid growth as a provider of clinical research in oncology and rare diseases.

Oncodesign Services has appointed Dr. Aidan Synnott as Chief Executive Officer, to help strengthen its position as a trusted partner in drug discovery.